Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Personalis, Inc. (PSNL)  
$1.57 0.08 (4.85%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 38,460,000
Market Cap: 60.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.9301 - $2.54
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    : 4.4
Insider 6 Months    : 4.4
Insider 3/6 Months : 9.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Personalis provides genetic tests for cancer. Co. also provides sequencing and data analysis services to support population sequencing initiatives. Co. operates and manages its business as one reportable operating segment, which is the sale of sequencing and data analysis services. Co.'s products include NeXT Platform, which is a platform that enable the analysis of both a tumor and its microenvironment from a single sample. Co. has created an ecosystem of products and capabilities built on the NeXT Platform: ImmunoID Next (tumor profiling from tissue), NeXT Liquid Biopsy (tumor profiling from plasma) and NeXT Personal (liquid biopsy providing for personalized tumor tracking for patients).


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 10,000 10,000 10,000 10,000
Total Buy Value $16,700 $16,700 $16,700 $16,700
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 4,523 22,702 41,220 125,853
Total Sell Value $6,197 $31,075 $69,252 $323,597
Total People Sold 1 3 3 4
Total Sell Transactions 1 9 17 49
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 196
  Page 2 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Chen Richard Chief Medical Officer   •       –      –    2022-12-20 4 S $1.92 $3,360 D/D (1,750) 133,193 -24%     
   Moore Stephen Michael General Counsel   •       –      –    2022-12-15 4 S $2.50 $4,825 D/D (1,930) 88,510 1%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-12-15 4 S $2.50 $17,943 D/D (7,177) 210,838 1%     
   Chen Richard Chief Medical Officer   •       –      –    2022-12-15 4 S $2.50 $17,943 D/D (7,177) 134,943 1%     
   West John Stephen President and CEO   •       •      –    2022-12-14 4 OE $2.44 $24,400 D/D 10,000 622,444     -
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-12-02 4 S $2.60 $11,336 D/D (4,360) 218,015 -7%     
   Chen Richard Chief Medical Officer   •       –      –    2022-12-02 4 S $2.60 $1,144 D/D (440) 142,120 -7%     
   Chen Richard Chief Medical Officer   •       –      –    2022-11-16 4 S $2.71 $3,509 D/D (1,295) 142,560 12%     
   Moore Stephen Michael General Counsel   •       –      –    2022-11-16 4 S $2.71 $5,542 D/D (2,045) 90,440 12%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-11-16 4 S $2.71 $3,507 D/D (1,294) 222,375 12%     
   Chen Richard Chief Medical Officer   •       –      –    2022-09-20 4 S $3.48 $5,502 D/D (1,581) 143,855 23%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-09-20 4 S $3.48 $12,090 D/D (3,474) 223,669 23%     
   Chen Richard Chief Medical Officer   •       –      –    2022-09-02 4 S $3.33 $1,399 D/D (420) 145,436 17%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-09-02 4 S $3.33 $13,879 D/D (4,168) 227,143 17%     
   West John Stephen President and CEO   •       •      –    2022-08-15 4 A $0.00 $0 D/D 230,000 612,444     -
   Moore Stephen Michael General Counsel   •       –      –    2022-08-15 4 A $0.00 $0 D/D 18,600 92,485     -
   Shoff Lonnie Director   –       •      –    2022-08-02 4 A $0.00 $0 D/D 30,940 30,940     -
   Chen Richard Chief Medical Officer   •       –      –    2022-07-28 4 S $3.91 $2,471 D/D (632) 145,856 34%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-07-28 4 S $3.91 $2,471 D/D (632) 231,311 34%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-06-17 4 S $3.29 $11,318 D/D (3,440) 231,943 19%     
   Chen Richard Chief Medical Officer   •       –      –    2022-06-17 4 S $3.29 $5,149 D/D (1,565) 146,488 19%     
   Moore Stephen Michael General Counsel   •       –      –    2022-06-15 4 S $3.24 $5,936 D/D (1,832) 73,885 22%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-06-15 4 S $3.24 $22,090 D/D (6,818) 235,383 22%     
   Chen Richard Chief Medical Officer   •       –      –    2022-06-15 4 S $3.24 $22,090 D/D (6,818) 148,053 22%     
   Chen Richard Chief Medical Officer   •       –      –    2022-06-02 4 S $3.59 $1,511 D/D (421) 154,871 30%     

  196 Records found
  1  2  3  4  5  6  7  8   
  Page 2 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed